Últimos Artículos de Terapeuthic Advances in Endocrinology and Metabolism
- Unrecognized primary aldosteronism may confound outcomes in adrenal Cushing’s syndrome
- From traditional to novel: a national cohort study on the predictive value of C-reactive protein–triglyceride–glucose-obesity composite parameters for cardiovascular disease
- Facilitators, barriers, and interventions for exercise adherence in patients with prediabetes: a mixed-methods systematic review
- Beyond glycemic control: clinical cardiovascular effects of tirzepatide—a narrative review
- GLP-1 receptor agonists in primary care: readiness, equity, and the risk of a two-tiered obesity treatment landscape
- Global burden of gout attributable to high BMI (1990–2021) and causal link with obesity: a GBD and Mendelian randomization study
- Chronic pancreatitis and pancreatogenic type 3c diabetes risk: a systematic review and meta-analysis
- Evaluation of electronic order set implementation in patients with diabetic ketoacidosis: a retrospective cohort study
- Automated insulin delivery use in a woman living with type 1 diabetes on peritoneal dialysis: a case report
- Determination of the relationship between raftlin, oxidative stress levels, and vitamin D receptor gene polymorphism in diabetic patients
- A Multinational Survey: The Impact of Living With Obesity on Well-Being: A Plain Language Summary
- Two threats in early life: congenital hyperinsulinemic hypoglycemia and thrombosis
- Lobectomy versus total thyroidectomy for unilateral multifocal papillary thyroid carcinoma (⩽4 cm) with limited lymph node metastasis: a retrospective cohort study using inverse probability weighting
- Be alert to hypertension caused by 17α-hydroxylase deficiency: two case reports in young patients
- Association between dietary intake of fatty acids, central obesity, and OAB: insights from a prospective cohort for weight management and dietary prevention
- Comparative 24-month cardiovascular outcomes and biomarker trajectories with semaglutide, empagliflozin, and sitagliptin in people with obesity and type 2 diabetes: a multicenter real-world study
- Diabetes-type-specific thyroid safety of GLP-1 receptor agonists: evidence from a large real-world cohort
- Response to the Letter by Zhang “The hidden variable in a ‘neutral’ upgrade: why parameter re-tuning and perceived reliability matter after G6 → G7 in Control-IQ”
- Association of prediabetes phenotypes with metabolic dysfunction-associated fatty liver disease and liver fibrosis: a population-based study
- Multisystem pathology in chronic variable stress: gut–liver–brain axis disruption and the therapeutic promise of magnesium-L-theanine